Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies
Status:
Withdrawn
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label, non-randomized study to evaluate the safety of two planned infusions
of BPX-501 T cells after partially mismatched, related (haploidentical) HSCT in adults with
hematologic malignancies.